Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
December 10, 2022
The article from Diário PcD, describes FDNA utilizes deep learning technology to assist Brazilian geneticists in diagnosing rare genetic diseases. This innovative tool employs advanced facial recognition and deep learning algorithms to analyze patient photos. By comparing facial features to a vast database of genetic conditions, Face2Gene provides rapid and precise diagnostic suggestions. This deep learning technology aids healthcare professionals, enhancing early diagnosis and personalized treatment plans. FDNA’s groundbreaking approach demonstrates the transformative potential of deep learning technology in medical diagnostics, making it easier and more efficient to identify rare genetic disorders and improve patient outcomes.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…